Discovery of a new potential treatment for visceral leishmaniasis - one of the world’s major neglected diseases
A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world’s major neglected diseases, has been discovered through a close collaboration between the University of Dundee, GSK and Wellcome.